ACTRN12618001479291进行中（未招募）未知
Comparisons of human embryonic development in culture medium with and without antioxidant supplementation
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 1,482
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 20 Years 至 o limit（—）
- 性别
- All
入选标准
- •Couples with female, male or unexplained infertility intending to undergo IVF or ICSI and where there are no medical contraindications to perform the treatment.
- •The couple should have received verbal and written information/consent about the study.
- •Blastocyst culture and fresh transfer on day 5 of a single embryo.
- •Concomitant medications (eg; use of any oral antioxidants) will be recorded
排除标准
- •Previous participation in the study.
- •Use of PGS where frozen embryo transfer is planned
- •Testicular biopsy patients (TESA/TESE)
- •Total freeze and no transfer possible.
研究者
相似试验
已完成
不适用
Comparison of Human Embryo Development Using Sequential and Single Media With Time-lapse ImagingInfertilityNCT01939626Vitrolife128
已完成
1 期
In Vitro Human Embryo Culture SystemInfertilityNCT00985218Incept BioSystems, Inc.40
已完成
不适用
Evaluation of a Closed Assisted Reproductive Technology (ART) Station Versus an Open Flow CabinetARTNCT03343938IVI Sevilla78
已完成
不适用
The effect of different media for sperm handling and injection at intracytoplasmic sperm injection (ICSI) on subsequent embryo cleavage: a comparison of the use of polyvinylpyrrolidone (PVP) and hyaluronan.Reproductive Health and Childbirth - Fertility including in vitro fertilisationInfertilityACTRN12613000957796Fertility North60
进行中（未招募）
不适用
Clinical study to compare recombinant human growth hormone Cristalia(r-hGH Cristalia) versus Genotropin® in prepubertal children withgrowth deficiency due to deficiency of growth hormone.Growth deficiency due to growth hormone deficiencyMedDRA version: 18.1Level: PTClassification code 10056438Term: Growth hormone deficiencySystem Organ Class: 10014698 - Endocrine disordersEUCTR2016-000446-56-Outside-EU/EEACristália Produtos Químicos Farmacêuticos Ltda.94